• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠和人脑中α-银环蛇毒素结合位点的死后稳定性

Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain.

作者信息

Davies P, Feisullin S

出版信息

Brain Res. 1981 Jul 20;216(2):449-54. doi: 10.1016/0006-8993(81)90148-7.

DOI:10.1016/0006-8993(81)90148-7
PMID:7248786
Abstract

The postmortem stability of alpha-bungarotoxin binding sites was examined in the brains of mice handled under conditions designed to simulate the handling of human autopsy material. No significant changes in the concentration of binding sites were evident up to 24 h after death. No correlation between the number of binding sites and the delay period between death and autopsy was found in studies of frontal cortex or mid-temporal gyrus from normal humans or cases of dementia of the Alzheimer type. Samples of mid-temporal gyrus from demented patients show a significant reduction in the number of binding sites.

摘要

在旨在模拟人类尸检材料处理条件下处理的小鼠大脑中,研究了α-银环蛇毒素结合位点的死后稳定性。直至死亡后24小时,结合位点浓度均未出现明显变化。在对正常人或阿尔茨海默病型痴呆病例的额叶皮质或颞中回研究中,未发现结合位点数量与死亡和尸检之间的延迟时间存在相关性。痴呆患者颞中回样本显示结合位点数量显著减少。

相似文献

1
Postmortem stability of alpha-bungarotoxin binding sites in mouse and human brain.小鼠和人脑中α-银环蛇毒素结合位点的死后稳定性
Brain Res. 1981 Jul 20;216(2):449-54. doi: 10.1016/0006-8993(81)90148-7.
2
Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.非神经疾病患者及阿尔茨海默型老年痴呆症患者大脑中的胆碱能受体结合与放射自显影
Brain Res. 1983 May 16;267(2):271-80. doi: 10.1016/0006-8993(83)90879-x.
3
Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease.
J Neurosci Res. 1990 Nov;27(3):349-59. doi: 10.1002/jnr.490270314.
4
Quantitative autoradiographic localization of [125I]alpha-bungarotoxin binding sites in the honeybee brain.
Brain Res. 1990 Nov 26;534(1-2):332-5. doi: 10.1016/0006-8993(90)90152-2.
5
Agonist-induced affinity alterations of a central nervous system alpha-bungarotoxin receptor.激动剂诱导的中枢神经系统α-银环蛇毒素受体亲和力改变
J Neurochem. 1979 Dec;33(6):1151-7. doi: 10.1111/j.1471-4159.1979.tb05258.x.
6
Subunit structure of alpha-bungarotoxin binding component in mouse brain.小鼠脑中α-银环蛇毒素结合成分的亚基结构
J Neurochem. 1981 Jul;37(1):210-6. doi: 10.1111/j.1471-4159.1981.tb05310.x.
7
Detection of low-affinity alpha-bungarotoxin binding sites in the rat central nervous system.大鼠中枢神经系统中低亲和力α-银环蛇毒素结合位点的检测
Biochemistry. 1984 Mar 13;23(6):1160-4. doi: 10.1021/bi00301a020.
8
Unmasking of cryptic binding sites for alpha -bungarotoxin in membrane fractions from chick retina.鸡视网膜膜组分中α-银环蛇毒素隐蔽结合位点的揭示
Biochem Biophys Res Commun. 1981 Oct 30;102(4):1385-92. doi: 10.1016/s0006-291x(81)80165-9.
9
Presence of an endogenous factor which inhibits binding of alpha-bungarotoxin 2.2 to its receptor.存在一种内源性因子,它能抑制α-银环蛇毒素2.2与其受体的结合。
Brain Res. 1982 Aug 5;245(1):57-67. doi: 10.1016/0006-8993(82)90339-0.
10
Higher expression of alpha7 nicotinic acetylcholine receptors in human fetal compared to adult brain.
Brain Res Dev Brain Res. 2003 May 14;142(2):151-60. doi: 10.1016/s0165-3806(03)00063-4.

引用本文的文献

1
Neuronal and Glial α7 Nicotinic Acetylcholine Receptors: Role in Alzheimer's Disease Pathophysiology.神经元和神经胶质细胞的α7烟碱型乙酰胆碱受体:在阿尔茨海默病病理生理学中的作用
Life (Basel). 2025 Jun 28;15(7):1032. doi: 10.3390/life15071032.
2
Imaging of Tauopathies with PET Ligands: State of the Art and Future Outlook.使用PET配体对tau蛋白病进行成像:现状与未来展望
Diagnostics (Basel). 2023 May 9;13(10):1682. doi: 10.3390/diagnostics13101682.
3
Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders.
α7烟碱型乙酰胆碱受体在脑部疾病中的生理功能及治疗应用
Pharmaceutics. 2022 Dec 22;15(1):31. doi: 10.3390/pharmaceutics15010031.
4
Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update.烟碱型乙酰胆碱受体激动剂治疗阿尔茨海默病的研究进展
Nicotine Tob Res. 2019 Feb 18;21(3):370-376. doi: 10.1093/ntr/nty116.
5
Brain PET Imaging of α7-nAChR with [18F]ASEM: Reproducibility, Occupancy, Receptor Density, and Changes in Schizophrenia.脑正电子发射断层扫描成像 α7-nAChR 与 [18F]ASEM:重现性、占有率、受体密度和精神分裂症的变化。
Int J Neuropsychopharmacol. 2018 Jul 1;21(7):656-667. doi: 10.1093/ijnp/pyy021.
6
[(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR.[125I]碘代ASEM,一种α7烟碱型乙酰胆碱受体的特异性体内放射性配体。
Nucl Med Biol. 2015 May;42(5):488-493. doi: 10.1016/j.nucmedbio.2014.12.008. Epub 2014 Dec 20.
7
Nicotinic ACh receptors as therapeutic targets in CNS disorders.烟碱型乙酰胆碱受体作为中枢神经系统疾病的治疗靶点。
Trends Pharmacol Sci. 2015 Feb;36(2):96-108. doi: 10.1016/j.tips.2014.12.002. Epub 2015 Jan 29.
8
The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited.烟碱型乙酰胆碱受体:重新审视吸烟与阿尔茨海默病
Front Biosci (Elite Ed). 2012 Jan 1;4(1):169-80. doi: 10.2741/367.
9
Brain imaging of nicotinic receptors in Alzheimer's disease.阿尔茨海默病中烟碱型受体的脑成像
Int J Alzheimers Dis. 2010 Dec 28;2010:548913. doi: 10.4061/2010/548913.
10
α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.α7烟碱受体激动剂:治疗精神分裂症和阿尔茨海默病认知障碍的潜在治疗药物。
Open Med Chem J. 2010 May 27;4:37-56. doi: 10.2174/1874104501004010037.